Ibrahim A. Abdelwahab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ibrahim A. Abdelwahab has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Abeer E. Abdel Wahab
Genetic Engineering and Biotechnology Research Institute (GEBRI), The City for Scientific Research and Technology Application, Borg El-Arab, Alexandria, Egypt
2 shared publications- Omaima G. Shaaban
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy & Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt
2 shared publications - Rania Abozahra
Microbiology and Immunology Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt
2 shared publications Abeer E Abdel Wahab
Genetic Engineering & Biotechnology Research Institute (GEBRI), the City for Scientific Research & Technology Application, Borg El-Arab, Alexandria, Egypt
1 shared publicationAlaa A. El-Tombary
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria 21521, Egypt
1 shared publicationAly A. B. Hazzaa
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt
1 shared publication
Latest Publications
- 12 November 2023
- Published by Egyptian Knowledge Bank in Egyptian Journal of Botany
- Vol. 64 (1) , 329-340
Evaluation of Azithromycin and Fenugreek Oil as Anti-virulence Agents against Stenotrophomonas maltophilia MultiDrug Resistant Clinical Isolates
Stenotrophomonas maltophilia is a gram-negative opportunistic pathogenic bacterium that is associated with hospital- and community-acquired infections. Ithas a set of virulence factors, such as biofilm formation and extracellular enzymes, that are mostly regulated via quorum sensing (QS) systems. Azithromycin (AZM) is a macrolide that is well known for its anti-virulence effects, including anti-QS and antibiofilm effects. Additionally, some spice essential oils have been reported to inhibit bacterial virulence. This study evaluated the effect of AZM and Fenugreek Oil (FO), a spice essential oil from Fenugreek seeds, against some virulence factors of multidrug-resistant Stenotrophomonas maltophilia clinical isolates. Both AZM and FO showed significant inhibitory effects against protease activity, where all tested isolates showed 100% loss of the halo zone formed in skimmed milk agar test with AZM and a 25 to 35% reduction in the zone with FO. A mean reduction in the interstitial surface area of 34.4% and 35.5% was detected with AZM and FO, respectively, in the twitching motility assay. While AZM showed a significant effect in reducing biofilm formation by S. maltophilia isolates (mean inhibition of 49.7%), the reducing effect of FO (18.5%) was not significant. Genotypically, exposure of S. maltophilia clinical isolates to AZM and FO significantly reduced the expression of protease-encoding genes (stmPr1, stmPr2 and StmPr3) and a quorum sensing gene (rpfC).
- 12 November 2023
- Published by Egyptian Knowledge Bank in Egyptian Journal of Botany
- Vol. 64 (1) , 329-340
Evaluation of Azithromycin and Fenugreek Oil as Anti-virulence Agents against Stenotrophomonas maltophilia MultiDrug Resistant Clinical Isolates
Stenotrophomonas maltophilia is a gram-negative opportunistic pathogenic bacterium that is associated with hospital- and community-acquired infections. Ithas a set of virulence factors, such as biofilm formation and extracellular enzymes, that are mostly regulated via quorum sensing (QS) systems. Azithromycin (AZM) is a macrolide that is well known for its anti-virulence effects, including anti-QS and antibiofilm effects. Additionally, some spice essential oils have been reported to inhibit bacterial virulence. This study evaluated the effect of AZM and Fenugreek Oil (FO), a spice essential oil from Fenugreek seeds, against some virulence factors of multidrug-resistant Stenotrophomonas maltophilia clinical isolates. Both AZM and FO showed significant inhibitory effects against protease activity, where all tested isolates showed 100% loss of the halo zone formed in skimmed milk agar test with AZM and a 25 to 35% reduction in the zone with FO. A mean reduction in the interstitial surface area of 34.4% and 35.5% was detected with AZM and FO, respectively, in the twitching motility assay. While AZM showed a significant effect in reducing biofilm formation by S. maltophilia isolates (mean inhibition of 49.7%), the reducing effect of FO (18.5%) was not significant. Genotypically, exposure of S. maltophilia clinical isolates to AZM and FO significantly reduced the expression of protease-encoding genes (stmPr1, stmPr2 and StmPr3) and a quorum sensing gene (rpfC).
- Open Access
- 23 March 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (2) , 1255-1265
Evaluation of Wound Healing Parameters and Antibacterial Effect of Jojoba and Citrullus colocynthis Oils in Staphylococcus Wound Infection Induced in Mice
Staphylococcus aureus is responsible for most bacterial wound infections. Antibiotics are the first-line treatment; however, their indiscriminate use led to the emergence of resistance. Alternative therapeutic options beyond antibiotic treatment are required. Our study aimed to evaluate and compare the healing parameters and antibacterial activity of Jojoba and Citrullus colocynthis oil extracts in the treatment of Staphylococcus aureus wound infections. In-vivo assessment of inflammatory biomarkers, matrix metalloproteinase and histopathological examination of Staphylococcus aureus induced wound lesions were conducted in mice. Levels of interleukin 1 and interleukin 6 were reduced, while matrix metalloproteinases ratio; MMP-1 /MMP-9 was increased after topical application of both essential oils. Citrullus colocynthis oil showed optimum wound healing compared to the other treated groups in histopathological examination. In conclusion, topical Citrullus colocynthis preparation may be a promising alternative natural dermatological application with enhanced antibacterial activity.
- 23 March 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (2) , 1255-1265
Open AccessEvaluation of Wound Healing Parameters and Antibacterial Effect of Jojoba and Citrullus colocynthis Oils in Staphylococcus Wound Infection Induced in Mice
Staphylococcus aureus is responsible for most bacterial wound infections. Antibiotics are the first-line treatment; however, their indiscriminate use led to the emergence of resistance. Alternative therapeutic options beyond antibiotic treatment are required. Our study aimed to evaluate and compare the healing parameters and antibacterial activity of Jojoba and Citrullus colocynthis oil extracts in the treatment of Staphylococcus aureus wound infections. In-vivo assessment of inflammatory biomarkers, matrix metalloproteinase and histopathological examination of Staphylococcus aureus induced wound lesions were conducted in mice. Levels of interleukin 1 and interleukin 6 were reduced, while matrix metalloproteinases ratio; MMP-1 /MMP-9 was increased after topical application of both essential oils. Citrullus colocynthis oil showed optimum wound healing compared to the other treated groups in histopathological examination. In conclusion, topical Citrullus colocynthis preparation may be a promising alternative natural dermatological application with enhanced antibacterial activity.
- Open Access
- 1 March 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (1) , 467-485
Interspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro
- 1 March 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (1) , 467-485
Open AccessInterspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro
- Open Access
Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine
Host response to COVID-19 vaccines is partially evaluated through the estimation of antibody response, specifically the binding anti-spike (anti-S) and the neutralizing antibodies (nAbs) against SARS-CoV-2. Vaccine-induced humoral response affects decisions on the choice of vaccine type, vaccine acceptance, and the need for boosting. Identification of risk factors for poor antibody response helps to stratify individuals who might potentially require booster doses. The primary objective of this cross-sectional study was to investigate the antibody response after receiving two Sinopharm vaccine doses. Factors affecting antibody response were additionally studied. Moreover, a predictive cutoff for anti-S was generated to predict positivity of nAbs. Blood samples were collected from 92 adults and relevant data were recorded. Antibody levels (anti-S and nAbs) against SARS-CoV-2 were tested one month following the second dose of Sinopharm vaccine using two commercial ELISA tests. Among the 92 participants, 88 tested positive for anti-S (95.7%), with a median level of 52.15 RU/mL (equivalent to 166.88 BAU/mL). Fewer participants (67.4%) were positive for nAbs, with a median percentage of inhibition (%IH) of 50.62% (24.05–84.36). A significant positive correlation existed between the titers of both antibodies (correlation coefficient = 0.875, p < 0.001). When the anti-S titer was greater than 40 RU/mL (128 BAU/mL), nAbs were also positive with a sensitivity of 80.6% and a specificity of 90%. Positive nAbs results were associated with a higher anti-S titers (62.1 RU/mL) compared to negative nAbs (mean anti-S titer of 18.6 RU/mL). History of COVID-19 infection was significantly associated with higher titers of anti-S (p = 0.043) and higher IH% of nAbs (p = 0.048). Hypertensive participants were found to have significantly higher median titers of anti-S (101.18 RU/mL) compared with non-hypertensive ones (42.15 RU/mL), p = 0.034. Post-vaccination headache was significantly higher among those with higher anti-S than those with relatively lower titers (98.82 versus 43.69 RU/mL, p = 0.048). It can be concluded that the Sinopharm vaccine produced high levels of binding antibodies but with low neutralizing abilities. Also, levels of anti-S titer greater than 40 RU/mL could adequately predict positivity of nAbs without need for their testing.
Open AccessAnti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine
Host response to COVID-19 vaccines is partially evaluated through the estimation of antibody response, specifically the binding anti-spike (anti-S) and the neutralizing antibodies (nAbs) against SARS-CoV-2. Vaccine-induced humoral response affects decisions on the choice of vaccine type, vaccine acceptance, and the need for boosting. Identification of risk factors for poor antibody response helps to stratify individuals who might potentially require booster doses. The primary objective of this cross-sectional study was to investigate the antibody response after receiving two Sinopharm vaccine doses. Factors affecting antibody response were additionally studied. Moreover, a predictive cutoff for anti-S was generated to predict positivity of nAbs. Blood samples were collected from 92 adults and relevant data were recorded. Antibody levels (anti-S and nAbs) against SARS-CoV-2 were tested one month following the second dose of Sinopharm vaccine using two commercial ELISA tests. Among the 92 participants, 88 tested positive for anti-S (95.7%), with a median level of 52.15 RU/mL (equivalent to 166.88 BAU/mL). Fewer participants (67.4%) were positive for nAbs, with a median percentage of inhibition (%IH) of 50.62% (24.05–84.36). A significant positive correlation existed between the titers of both antibodies (correlation coefficient = 0.875, p < 0.001). When the anti-S titer was greater than 40 RU/mL (128 BAU/mL), nAbs were also positive with a sensitivity of 80.6% and a specificity of 90%. Positive nAbs results were associated with a higher anti-S titers (62.1 RU/mL) compared to negative nAbs (mean anti-S titer of 18.6 RU/mL). History of COVID-19 infection was significantly associated with higher titers of anti-S (p = 0.043) and higher IH% of nAbs (p = 0.048). Hypertensive participants were found to have significantly higher median titers of anti-S (101.18 RU/mL) compared with non-hypertensive ones (42.15 RU/mL), p = 0.034. Post-vaccination headache was significantly higher among those with higher anti-S than those with relatively lower titers (98.82 versus 43.69 RU/mL, p = 0.048). It can be concluded that the Sinopharm vaccine produced high levels of binding antibodies but with low neutralizing abilities. Also, levels of anti-S titer greater than 40 RU/mL could adequately predict positivity of nAbs without need for their testing.
- Open Access
- 3 January 2022
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 16 (1) , 138-146
Diabetic Foot Ulcer Infections and Pseudomonas aeruginosa Biofilm Production During the COVID-19 Pandemic
During the different waves of the coronavirus (COVID-19) pandemic, there has been an increased incidence of diabetes mellitus and diabetic foot infections. Among gram-negative bacteria, Pseudomonas aeruginosa is the predominant causative agent for diabetic foot ulcer infections in low-resource countries. P. aeruginosa possesses a variety of virulence factors, including biofilm formation. Biofilm formation is an important benchmark characteristic in the pathophysiology of diabetic foot ulceration. The main objective of the current study was to identify the most commonly isolated organisms and their antibiotic susceptibility patterns in diabetic foot patients during the COVID-19 pandemic. We also determined the genes associated with bacterial persistence and biofilm formation in the predominantly isolated organism. Accordingly, 100 wound swab samples were collected from diabetic foot patients from different hospitals in Alexandria, Egypt. Through phenotypic detection of biofilm formation, 93% (40) of the 43 P. aeruginosa isolates examined were categorized as biofilm producers. Molecular detection of the biofilm-encoding genes among the 43 P. aeruginosa isolates was as follows: algD (100%), pelF (88%) and pslD (49.7%), and this highlights a need for biofilm formation inhibitors to prevent the persistence of bacterial pathogens, and thus achieve better clinical outcomes in diabetic foot ulcer infections.
- 3 January 2022
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 16 (1) , 138-146
Open AccessDiabetic Foot Ulcer Infections and Pseudomonas aeruginosa Biofilm Production During the COVID-19 Pandemic
During the different waves of the coronavirus (COVID-19) pandemic, there has been an increased incidence of diabetes mellitus and diabetic foot infections. Among gram-negative bacteria, Pseudomonas aeruginosa is the predominant causative agent for diabetic foot ulcer infections in low-resource countries. P. aeruginosa possesses a variety of virulence factors, including biofilm formation. Biofilm formation is an important benchmark characteristic in the pathophysiology of diabetic foot ulceration. The main objective of the current study was to identify the most commonly isolated organisms and their antibiotic susceptibility patterns in diabetic foot patients during the COVID-19 pandemic. We also determined the genes associated with bacterial persistence and biofilm formation in the predominantly isolated organism. Accordingly, 100 wound swab samples were collected from diabetic foot patients from different hospitals in Alexandria, Egypt. Through phenotypic detection of biofilm formation, 93% (40) of the 43 P. aeruginosa isolates examined were categorized as biofilm producers. Molecular detection of the biofilm-encoding genes among the 43 P. aeruginosa isolates was as follows: algD (100%), pelF (88%) and pslD (49.7%), and this highlights a need for biofilm formation inhibitors to prevent the persistence of bacterial pathogens, and thus achieve better clinical outcomes in diabetic foot ulcer infections.
- Open Access
- 5 September 2020
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 14 (1) , 205-212
A Nanoparticles based Microbiological Study on the Effect of Rosemary and Ginger Essential Oils against Klebsiella pneumoniae.
Background: Klebsiella pneumoniae is a nosocomial pathogen in outbreaks of hospital infections. It is one of the major factors for morbidity and mortality in hospitalized patients especially those infected with colistin-resistant pathogens. Many plant essential oils have antimicrobial activities and have been investigated as natural sources to combat multiple antibiotic resistances. Moreover, recent advances in phytonanotechnology have created exciting opportunities for the management of many infections. Objective: This study aims at investigating the antimicrobial and antibiofilm effect of rosemary and ginger essential oil-based nano-sized formulations on colistin resistant K. pneumonia clinical isolates. Methods: Isolation and identification of 30 K. pneumonia isolates from different human samples were done followed by antibiotic susceptibility testing and detection of biofilm gene (mrkD). Examination of the activity of the tested essential oils and their chitosan nanoparticle formulations against the selected isolates was made by determination of their MICs using broth microdilution method followed by biofilm inhibition test and quantitative real-time PCR for the expression of mrkD gene in the presence of the oils and nanoparticles formulations compared to untreated bacterial isolates. Results: Our results showed that the minimum inhibitory concentration of rosemary and ginger oils was 1250 μg/ml, that of nanostructured lipid carrier-rosemary oil and nanostructured lipid carrier-ginger oil was 625 μg/ml and rosemary oil loaded chitosan nanoparticles and ginger oil loaded chitosan nanoparticles possessed minimum inhibitory concentration of 156 μg/ml. Results also revealed complete (100%) inhibition for mrkD gene expression when compared to untreated K. pneumonia. Conclusion: Oil loaded chitosan nanoparticles showed the highest antimicrobial and antibiofilm activity.
- 5 September 2020
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 14 (1) , 205-212
Open AccessA Nanoparticles based Microbiological Study on the Effect of Rosemary and Ginger Essential Oils against Klebsiella pneumoniae.
Background: Klebsiella pneumoniae is a nosocomial pathogen in outbreaks of hospital infections. It is one of the major factors for morbidity and mortality in hospitalized patients especially those infected with colistin-resistant pathogens. Many plant essential oils have antimicrobial activities and have been investigated as natural sources to combat multiple antibiotic resistances. Moreover, recent advances in phytonanotechnology have created exciting opportunities for the management of many infections. Objective: This study aims at investigating the antimicrobial and antibiofilm effect of rosemary and ginger essential oil-based nano-sized formulations on colistin resistant K. pneumonia clinical isolates. Methods: Isolation and identification of 30 K. pneumonia isolates from different human samples were done followed by antibiotic susceptibility testing and detection of biofilm gene (mrkD). Examination of the activity of the tested essential oils and their chitosan nanoparticle formulations against the selected isolates was made by determination of their MICs using broth microdilution method followed by biofilm inhibition test and quantitative real-time PCR for the expression of mrkD gene in the presence of the oils and nanoparticles formulations compared to untreated bacterial isolates. Results: Our results showed that the minimum inhibitory concentration of rosemary and ginger oils was 1250 μg/ml, that of nanostructured lipid carrier-rosemary oil and nanostructured lipid carrier-ginger oil was 625 μg/ml and rosemary oil loaded chitosan nanoparticles and ginger oil loaded chitosan nanoparticles possessed minimum inhibitory concentration of 156 μg/ml. Results also revealed complete (100%) inhibition for mrkD gene expression when compared to untreated K. pneumonia. Conclusion: Oil loaded chitosan nanoparticles showed the highest antimicrobial and antibiofilm activity.
- 7 August 2019
- Published by Wiley in Archiv der Pharmazie
- Vol. 352 (10) , 1900086
Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids
Antibiotic‐resistant bacteria continue to play an important role in human health and disease. Inventive strategies are necessary to develop new therapeutic leads to challenge drug‐resistance problems. From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized. The newly synthesized compounds were evaluated for their in vitro antibacterial activity against nine bacterial pathogenic strains. The results revealed that most compounds exhibited good antibacterial activities. Seven compounds (2b, 3b, 4, 6, 8b, and 9c,d) displayed enhanced activity against methicillin‐resistant Staphylococcus aureus compared to ampicillin. These compounds were subjected to an in vitro S. aureus DNA gyrase ATPase inhibition study, which revealed that compounds 8b, 9c, and 9d showed the highest inhibitory activity with IC50 values of 1.89, 2.73, and 2.14 μM, respectively, comparable to novobiocin (IC50, 1.636 μM). Compounds 2a–c, 3a, 7c, 9c,d, and 10a,b revealed half the potency of levofloxacin in inhibiting the growth of Pseudomonas aeruginosa. As an attempt to rationalize the observed antibacterial activity for the most active compounds 8b, 9c, and 9d, molecular docking in the ATP binding site of S. aureus gyrase B was performed using Glide. Such compounds could be considered as promising scaffolds for the development of new potent antibacterial agents.
- 7 August 2019
- Published by Wiley in Archiv der Pharmazie
- Vol. 352 (10) , 1900086
Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids
Antibiotic‐resistant bacteria continue to play an important role in human health and disease. Inventive strategies are necessary to develop new therapeutic leads to challenge drug‐resistance problems. From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized. The newly synthesized compounds were evaluated for their in vitro antibacterial activity against nine bacterial pathogenic strains. The results revealed that most compounds exhibited good antibacterial activities. Seven compounds (2b, 3b, 4, 6, 8b, and 9c,d) displayed enhanced activity against methicillin‐resistant Staphylococcus aureus compared to ampicillin. These compounds were subjected to an in vitro S. aureus DNA gyrase ATPase inhibition study, which revealed that compounds 8b, 9c, and 9d showed the highest inhibitory activity with IC50 values of 1.89, 2.73, and 2.14 μM, respectively, comparable to novobiocin (IC50, 1.636 μM). Compounds 2a–c, 3a, 7c, 9c,d, and 10a,b revealed half the potency of levofloxacin in inhibiting the growth of Pseudomonas aeruginosa. As an attempt to rationalize the observed antibacterial activity for the most active compounds 8b, 9c, and 9d, molecular docking in the ATP binding site of S. aureus gyrase B was performed using Glide. Such compounds could be considered as promising scaffolds for the development of new potent antibacterial agents.
- 1 July 2019
- Published by Elsevier in Bioorganic Chemistry
- Vol. 88, 102934
Synthesis and molecular docking study of some 3,4-dihydrothieno[2,3-d]pyrimidine derivatives as potential antimicrobial agents
- 1 July 2019
- Published by Elsevier in Bioorganic Chemistry
- Vol. 88, 102934
Synthesis and molecular docking study of some 3,4-dihydrothieno[2,3-d]pyrimidine derivatives as potential antimicrobial agents
- 8 August 2018
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 10 (18) , 2155-2175
Synthesis of pyrazolo-1,2,4-triazolo[4,3- a ]quinoxalines as Antimicrobial Agents with Potential Inhibition of DHPS Enzyme
Aim: The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. Experimental: This study aims to design and synthesize a series of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines, to develop agents having antimicrobial activity through potential inhibition of dihyropteroate synthase enzyme. The target compounds have been evaluated for their in-vitro antimicrobial activity. Results & discussion: Compounds 5b, 5c were equipotent (minimal inhibitory concentration = 12.5 μg/ml) to ampicillin. The docking patterns of 5b and 5c demonstrated that both fit into Bacillus Anthracis dihydropteroate synthase pterin and p-amino benzoic acid-binding pockets. Moreover, their physicochemical properties and pharmacokinetic profiles recommend that they can be considered drug-like candidates. The results highlight some significant information for the future design of lead compounds as antimicrobial agents. Graphical abstract
- 8 August 2018
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 10 (18) , 2155-2175
Synthesis of pyrazolo-1,2,4-triazolo[4,3- a ]quinoxalines as Antimicrobial Agents with Potential Inhibition of DHPS Enzyme
Aim: The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. Experimental: This study aims to design and synthesize a series of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines, to develop agents having antimicrobial activity through potential inhibition of dihyropteroate synthase enzyme. The target compounds have been evaluated for their in-vitro antimicrobial activity. Results & discussion: Compounds 5b, 5c were equipotent (minimal inhibitory concentration = 12.5 μg/ml) to ampicillin. The docking patterns of 5b and 5c demonstrated that both fit into Bacillus Anthracis dihydropteroate synthase pterin and p-amino benzoic acid-binding pockets. Moreover, their physicochemical properties and pharmacokinetic profiles recommend that they can be considered drug-like candidates. The results highlight some significant information for the future design of lead compounds as antimicrobial agents. Graphical abstract
- 1 February 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 76, 437-448
Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme
- 1 February 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 76, 437-448
Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme